Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Pricing 'Deeper Dive' Planned By Senate Cmte. As Industry Avoids First Blood

Jun 14 2017

• By Cathy Kelly

Capitol House

Related Content

Drug Pricing ‘Opacity,’ Degrees Of Transparency Debated By National Academies Panel

Jan 10 2017

Medicare Part D Catastrophic Spending Surge Needs Solutions, OIG Says

Jan 06 2017

Trump Drug Pricing Plan May Include Rebate Pass-Through Push – Novartis CEO

Jun 02 2017

Additional Topics

United States Policy Pricing Debate Legislation BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.